DalsnaFinance › IPOs › Regentis Biomaterials › IPO
REGENTIS BIOMATERIALS LTD. completed its initial public offering on NYSE on December 4, 2025, pricing at $8.00 a share.
| Ticker | RGNT |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | December 4, 2025 |
| Offering price | $8.00 |
| Shares offered | 1,250,000 |
| Total raised | $10M |
REGENTIS BIOMATERIALS LTD. sold 1,250,000 shares at $8.00 each on NYSE. Multiplied out, that is $10 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $10 million total recorded for the deal.
Measured by money raised, REGENTIS BIOMATERIALS LTD. was tied for the 449th largest (level with 24 other deals) of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 126 listings on NYSE alone, it is tied for the 114th largest (level with 12 other listings).
December 2025 saw 34 completed IPOs in the site's data; by amount raised, REGENTIS BIOMATERIALS LTD. was tied for the 32nd largest (level with 2 other deals) of the 34 deals with a recorded size.
Its $8.00 offer price was tied for the 409th highest (level with 5 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
REGENTIS BIOMATERIALS LTD. — quote, profile and latest news →
Source: SEC EDGAR filings for REGENTIS BIOMATERIALS LTD.. This page is general information, not investment advice.